Exosomes as a novel nanomedicine platform for personalized triple-negative breast cancer therapy

Nanomedicine (Lond). 2023 Mar;18(6):501-504. doi: 10.2217/nnm-2023-0074. Epub 2023 May 17.

Authors

Abhishesh Kumar Mehata¹, Niharika Gupta², Madaswamy S Muthu¹

Affiliations

¹ Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (BHU), Varanasi, 221005, India.
² Department of Botany, Institute of Science (BHU), Varanasi, 221005, India.

PMID: 37194721
DOI: 10.2217/nnm-2023-0074

No abstract available

Keywords: exosomes; personalized nanomedicine; theranostics; triple-negative breast cancer.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Cell Line, Tumor
Exosomes*
Humans
Nanomedicine
Triple Negative Breast Neoplasms* / drug therapy